“Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling” (2025) The Review of Diabetic Studies, pp. 496–510. doi:10.70082/y1zx3j95.